NZ542432A - Crystalline N-formyl hydroxylamine compounds - Google Patents
Crystalline N-formyl hydroxylamine compoundsInfo
- Publication number
- NZ542432A NZ542432A NZ542432A NZ54243204A NZ542432A NZ 542432 A NZ542432 A NZ 542432A NZ 542432 A NZ542432 A NZ 542432A NZ 54243204 A NZ54243204 A NZ 54243204A NZ 542432 A NZ542432 A NZ 542432A
- Authority
- NZ
- New Zealand
- Prior art keywords
- crystalline
- salt
- formula
- magnesium salt
- crystalline magnesium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45972603P | 2003-04-02 | 2003-04-02 | |
| PCT/EP2004/003478 WO2004087133A1 (en) | 2003-04-02 | 2004-04-01 | Crystalline n-formyl hydroxylamine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ542432A true NZ542432A (en) | 2009-04-30 |
Family
ID=33131903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ542432A NZ542432A (en) | 2003-04-02 | 2004-04-01 | Crystalline N-formyl hydroxylamine compounds |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20070135353A1 (https=) |
| EP (1) | EP1613305A1 (https=) |
| JP (1) | JP2006522054A (https=) |
| KR (1) | KR20060002915A (https=) |
| CN (1) | CN1764450A (https=) |
| AR (1) | AR043804A1 (https=) |
| AU (1) | AU2004226815B2 (https=) |
| BR (1) | BRPI0409009A (https=) |
| CA (1) | CA2520682A1 (https=) |
| CL (1) | CL2004000705A1 (https=) |
| CO (1) | CO5630028A2 (https=) |
| EC (1) | ECSP056043A (https=) |
| IS (1) | IS8093A (https=) |
| MA (1) | MA27763A1 (https=) |
| MX (1) | MXPA05010610A (https=) |
| MY (1) | MY136854A (https=) |
| NO (1) | NO20055097L (https=) |
| NZ (1) | NZ542432A (https=) |
| PE (1) | PE20050392A1 (https=) |
| RU (1) | RU2005133660A (https=) |
| SG (1) | SG166681A1 (https=) |
| TN (1) | TNSN05248A1 (https=) |
| TW (1) | TW200427458A (https=) |
| WO (1) | WO2004087133A1 (https=) |
| ZA (1) | ZA200507179B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1406893B1 (en) | 2001-06-15 | 2007-04-18 | Vicuron Pharmaceuticals, Inc. | Pyrrolidine bicyclic compounds |
| ATE417826T1 (de) | 2002-09-19 | 2009-01-15 | Novartis Pharma Gmbh | Verfahren zur herstellung von zwischenprodukten |
| MXPA05008842A (es) | 2003-02-21 | 2005-10-05 | Novartis Ag | Proceso quimico. |
| GT200600196A (es) * | 2005-05-23 | 2007-01-15 | Compuestos n-formil de hidroxilamina | |
| JP7001898B2 (ja) * | 2016-05-11 | 2022-01-20 | グアンドン・ヘボ・ファーマシューティカル・カンパニー・リミテッド | スピロ３員環、スピロ５員環系ペプチドデホルミラーゼ阻害剤および抗菌と抗腫瘍におけるその使用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3282986A (en) * | 1960-10-06 | 1966-11-01 | Merck & Co Inc | N-acylated hydroxamic acids and derivatives thereof |
| DK1052984T3 (da) * | 1998-02-07 | 2004-09-20 | Vernalis Oxford Ltd | Antibakterielle midler |
| AR036053A1 (es) * | 2001-06-15 | 2004-08-04 | Versicor Inc | Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas |
-
2004
- 2004-03-29 TW TW093108548A patent/TW200427458A/zh unknown
- 2004-03-31 AR ARP040101079A patent/AR043804A1/es not_active Application Discontinuation
- 2004-03-31 PE PE2004000339A patent/PE20050392A1/es not_active Application Discontinuation
- 2004-04-01 MX MXPA05010610A patent/MXPA05010610A/es unknown
- 2004-04-01 CN CNA2004800078725A patent/CN1764450A/zh active Pending
- 2004-04-01 AU AU2004226815A patent/AU2004226815B2/en not_active Ceased
- 2004-04-01 SG SG200801365-8A patent/SG166681A1/en unknown
- 2004-04-01 MY MYPI20041200A patent/MY136854A/en unknown
- 2004-04-01 JP JP2006504952A patent/JP2006522054A/ja active Pending
- 2004-04-01 WO PCT/EP2004/003478 patent/WO2004087133A1/en not_active Ceased
- 2004-04-01 KR KR1020057018676A patent/KR20060002915A/ko not_active Ceased
- 2004-04-01 CL CL200400705A patent/CL2004000705A1/es unknown
- 2004-04-01 EP EP04725014A patent/EP1613305A1/en not_active Ceased
- 2004-04-01 RU RU2005133660/04A patent/RU2005133660A/ru not_active Application Discontinuation
- 2004-04-01 NZ NZ542432A patent/NZ542432A/en unknown
- 2004-04-01 CA CA002520682A patent/CA2520682A1/en not_active Abandoned
- 2004-04-01 US US10/550,631 patent/US20070135353A1/en not_active Abandoned
- 2004-04-01 BR BRPI0409009-8A patent/BRPI0409009A/pt not_active IP Right Cessation
-
2005
- 2005-09-07 ZA ZA200507179A patent/ZA200507179B/en unknown
- 2005-09-28 EC EC2005006043A patent/ECSP056043A/es unknown
- 2005-09-30 TN TNP2005000248A patent/TNSN05248A1/en unknown
- 2005-10-04 CO CO05100510A patent/CO5630028A2/es not_active Application Discontinuation
- 2005-10-11 MA MA28547A patent/MA27763A1/fr unknown
- 2005-10-27 IS IS8093A patent/IS8093A/is unknown
- 2005-11-01 NO NO20055097A patent/NO20055097L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20055097L (no) | 2005-12-22 |
| CA2520682A1 (en) | 2004-10-14 |
| US20070135353A1 (en) | 2007-06-14 |
| RU2005133660A (ru) | 2006-06-10 |
| AU2004226815B2 (en) | 2007-07-19 |
| PE20050392A1 (es) | 2005-06-19 |
| TNSN05248A1 (en) | 2007-06-11 |
| MXPA05010610A (es) | 2005-11-23 |
| BRPI0409009A (pt) | 2006-03-28 |
| IS8093A (is) | 2005-10-27 |
| AU2004226815A1 (en) | 2004-10-14 |
| CO5630028A2 (es) | 2006-04-28 |
| SG166681A1 (en) | 2010-12-29 |
| CL2004000705A1 (es) | 2005-01-14 |
| WO2004087133A1 (en) | 2004-10-14 |
| MA27763A1 (fr) | 2006-02-01 |
| MY136854A (en) | 2008-11-28 |
| ZA200507179B (en) | 2006-04-26 |
| NO20055097D0 (no) | 2005-11-01 |
| KR20060002915A (ko) | 2006-01-09 |
| ECSP056043A (es) | 2006-01-27 |
| JP2006522054A (ja) | 2006-09-28 |
| TW200427458A (en) | 2004-12-16 |
| EP1613305A1 (en) | 2006-01-11 |
| AR043804A1 (es) | 2005-08-10 |
| CN1764450A (zh) | 2006-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100878074B1 (ko) | 무티린 유도체 및 항균제로서의 그의 용도 | |
| JP2003506354A5 (https=) | ||
| CN113614092A (zh) | 提供抗革兰氏阳性细菌增强的抗菌活性的组合物及其用途 | |
| DK152213B (da) | Fremgangsmaade til fremstilling af en krystallinsk form af natriumsaltet af et oximderivat af 7-aminothiazolylacetamidocephalosporansyre | |
| HUP0203226A2 (hu) | Hatóanyagként benzamidszármazékot tartalmazó gyógyszerkészítmény | |
| AU2004226815B2 (en) | Crystalline N-formyl hydroxylamine compounds | |
| US9695119B2 (en) | Methionine analogs and methods of using same | |
| US10864222B1 (en) | Beta-lactamase inhibitors, formulations, and uses thereof | |
| BRPI0611369A2 (pt) | compostos de n-formil hidroxilamina | |
| WO2002062337A1 (en) | Thiazolidinediones | |
| JP2018516953A (ja) | 抗菌組成物 | |
| JP6626516B2 (ja) | 抗菌組成物及び方法 | |
| RU2741764C2 (ru) | Лизобактин для применения для лечения коровьего мастита | |
| JPS6254313B2 (https=) | ||
| RU2021259C1 (ru) | Производные амида акриловой кислоты или их соли с органическим или неорганическим основанием, обладающие цитопротекторной и противоязвенной активностью, и состав, обладающий цитопротекторной и противоязвенной активностью | |
| WO2024175768A1 (en) | Combination of fabi inhibitor and antibiotic agent | |
| WO2021243015A1 (en) | Antibacterial compounds | |
| JP2008534444A (ja) | 新規な方法 | |
| CA3172170A1 (en) | Use of bucillamine in the treatment of infectious diseases | |
| JP2008534443A (ja) | 新規な方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| PSEA | Patent sealed |